 |
 |

Detection of Metastatic Liver DiseaseUse of Liver Scans and Biochemical Liver Tests
Margaret A. Tempero, MD;
Richard J. Petersen, MD;
Rowen K. Zetterman, MD;
Henry M. Lemon, MD;
Jud Gurney, MD
JAMA. 1982;248(11):1329-1332.
Abstract
 |  |
The records of 94 patients with a known diagnosis of extrahepatic cancer having liver scan, biochemical liver tests (alkaline phosphatase, SGOT, lactic dehydrogenase, and bilirubin levels, and subsequent liver biopsy within a six-week period were reviewed. The sensitivity, specificity, and accuracy of the scan and biochemical tests in the detection of metastatic liver disease were calculated. The most sensitive single examination was the group of biochemical liver tests. Liver scans performed in the presence of normal biochemical test results were insensitive when compared with the liver scan alone or the liver scan in the presence of abnormal biochemical test results. The specificity and accuracy of all tests and test combinations were statistically equivalent. Screening for hepatic metastases in patients with cancer is best accomplished with the more sensitive and less expensive group of biochemical liver tests, reserving the liver scan for those patients with abnormal biochemical test results.
(JAMA 1982;248:1329-1332)
Author Affiliations
From the Sections of Oncology (Drs Tempero and Lemon) and Gastroenterology (Dr Zetterman), Department of Internal Medicine, and the Department of Radiology (Dr Gurney), University of Nebraska Medical Center, and the Department of Radiology, Bishop Clarkson Memorial Hospital (Dr Petersen), Omaha.
Footnotes
Reprint requests to Section of Oncology, Department of Internal Medicine, University of Nebraska Medical Center, 42nd Street and Dewey Avenue, Omaha, NE 68105 (Dr Tempero).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Use of Methodological Standards in Diagnostic Test Research: Getting Better but Still Not Good
Reid et al.
JAMA 1995;274:645-651.
ABSTRACT
Evaluation of Head and Neck Cancer Patients: A National Survey
Swann and Blakeslee
Arch Otolaryngol Head Neck Surg 1988;114:775-778.
ABSTRACT
A Case Study of Physicians' Use of Liver-Spleen Scans: Are We Doing What We Think We're Doing?
Steinberg et al.
Arch Intern Med 1986;146:253-258.
ABSTRACT
Diagnosis of Metastatic Liver Cancer-Reply
Silberstein
JAMA 1984;252:1280-1280.
ABSTRACT
|